Johns Hopkins study shows that markers of poor blood sugar control reflect lower extremity disease in patients with diabetes. Elevated hemoglobin A1C and glycated albumin result in increased risk of peripheral artery disease and peripheral neuropathy.

Through participation in the international organization offering opportunities to bolster patient care and innovate surgical practice via landmark clinical trials, Johns Hopkins seeks to expand its cardiothoracic program.